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Novel series of dialkylaminoalkyl-o-cresols incorporated with purine nucleus 2aeb, ben-
zothiazole nucleus 5aeb, 8aeb and thiazole nucleus 11aed, 13aed were synthesized
through Mannich reaction. Structures of the newly synthesized compounds have been
deduced on the basis of elemental analysis and spectral data. Antimicrobial activity
evaluation was carried out for all synthesized compounds; most of them exerted compa-
rable activity to ciprofloxacin and flucanazole. The thiazole derivatives 11a, 13c, 13d are
the most potent compounds.
Copyright 2015, Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
The resistance to antimicrobial drugs is widespread; there is
an increasing need for identification of novel structure leads
that may be of use in designing new, potent and less toxic
antimicrobial agents. The previous literature survey revealed
that certain phenolic Mannich bases (Magarian and Sorenson,
1976; Pernak et al., 1999), purine (Bakkestuen et al., 2000;
Gundersen et al., 2002), benzothiazole (Abdel-Rahman and
Morsy, 2007; Hilal et al., 2006; Vicini et al., 2008; Yamazaki
et al., 2005) and thiazole (Bozdag-Dundar et al., 2007;4; fax: þ20 082 2317958.
u.edu.eg (K.R.A. Abdellat
i-Suef University.
ity. Production and hosti
licenses/by-nc-nd/4.0/).Karegoudar et al., 2008; Ozdemir et al., 2007; Vicini et al.,
2006) derivatives exhibited significant antibacterial and anti-
fungal activities. At the same time, presence of azo group
(Bondock et al., 2007) or azomethine group (Chohan et al.,
2003) enhances the antimicrobial activity of the above
mentioned nuclei. Also, the introduction of an amidic linkage
into the heteroaromatic ring systems increases its biological
activity by increasing the lipophilicity of these compounds
which facilitates their penetration into the bacterial and
fungal cells (Turan-Zitouni et al., 2004, 2005; Zimenkovskii
et al., 2006). In view of the aforementioned findings, it wasif).
ng by Elsevier B.V. This is an open access article under the CC BY-
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and some heteroaromatic ring systems via one of the above
pharmacophoric groups. Accordingly and in continuation of
our previous work (Abdellatif et al., 2014), we now report
combination between purine nucleus with dialkylamino-o-
cresol moieties via an amidic linkage (2aeb), or an incorpo-
ration of a benzothiazole ring system with phenolic Mannich
bases through the pharmacophoric azomethine group (5aeb)
or via an amidic linkage (8aeb). Moreover, a number of
substituted thiazoles incorporated with dialkylamino-o-cresol
moieties via azo group (11aed, 13aed) with the aim that the
target compounds may show good antimicrobial activity.2. Experimental
2.1. Chemistry
2.1.1. General
Melting points were determined on a Griffin apparatus and are
uncorrected. Infrared (IR) spectra were recorded on a Shi-
madzu 435 Spectrometer, using KBr discs and values were
represented in cm-1. 1H NMR spectra were measured on a
Varian Gemini 300 MHz spectrometer in CDCl3 or DMSO-d6
with TMS as the internal standard. Mass spectra were run on
Hewlett Packard 5988 spectrometer. Microanalyses were per-
formed for C, H, N (Micro Analytical Centre, Cairo University,
Egypt) andwerewithin± 0.4% of theoretical values. Progress of
the reactions was monitored by TLC using TLC sheets pre-
coated with UV fluorescent silica gel MERCK 60 F 254 that was
visualized by UV lamp. 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-
tetrahydropurin-7-yl)-N-(4-hydroxyphenyl)acetamide (1), 4-
benzothiazol-2-yl-phenylamine (3) (Shi et al., 1996), 4-[(4-
benzothiazol-2-yl-phenylimino)-methyl]-phenol (4)
(Nagarajan et al., 2010), N-(4-benzothiazol-2-yl-phenyl)-2-
chloroacetamide (6) (Chua et al., 1999; Pan et al., 2013), 4-
phenylthiazol-2-ylamine (9a) (Dodson and King, 1945), 4-(4-
methylphenyl)thiazol-2-ylamine (9b) (King and Hlavacek,
1950), 2-amino-4-methylthiazole-5-carboxylic acid ethyl
ester (9c) (Dodson and King, 1945), 4-(4-phenylthiazol-2-ylazo)
phenol (10a), and 2-(4-hydroxy-phenylazo)-4-methylthiazole-




(2a). To a solution of the purine derivative 1 (1.64 gm, 5mmol)
in dimethylformamide (15 mL), a mixture of diethylamine
(6 mmol) and formaldehyde solution (37e40%) (0.62 mL,
7.5 mmol) in glacial acetic acid (5 mL) was added drop wise.
After complete addition, the reaction mixture was stirred at
room temperature for 12 h then poured onto ice-cooled water.
The formed precipitate was filtered, dried and crystallized
from dimethylformamide/water to afford 1.39 g of 2a (67%
yield); mp 249e250; IR (cm1) 3306, 3257 (OH&NH), 3162, 3086
(CH aromatic), 2984, 2878 (CH aliphatic), 1703, 1651 (amidic C]
O), 1555 (C]N), 1518 (C]C aromatic); 1H NMR (DMSO-d6) d 0.95
(t, J¼ 7.5 Hz, 6H, H3CeH2CeNeCH2eCH3), 2.74 (q, J¼ 7.5 Hz, 4H,
H3CeH2CeNeCH2eCH3), 3.17 (s, 3H, purinyl N3eCH3), 3.42 (s,
3H, purinyl N1eCH3), 3.55 (s, 2H, CH2N); 5.13 (s, 2H, CH2CO),6.68e6.72 (m, 2H, phenyl H-2, H-6), 7.35 (d, J ¼ 8.1 Hz, 1H,
phenyl H-5), 8.04 (s, 1H, purinyl H-8), 9.33 (s, 1H, NH, D2O
exchangeable), 10.17 (s, 1H, OH, D2O exchangeable); EIMS 414
(Mþ). Anal. Calcd for C20H26N6O4: C, 57.96; H, 6.32; N, 20.28.
Found: C, 58.22; H, 6.29; N, 20.40.
2.1.1.2. 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-
yl)-N-[4-hydroxy-3-(4-methylpiperidin-1-ylmethyl)-phenyl]-
acetamide (2b). The title compound 2bwas synthesized, using
a similar procedure to that described for the preparation of 2a,
by using 4-methylpiperidine in place of diethylamine, in 80%
yield as a pale brown powder; mp 188e190 C; IR (cm1) 3300,
3200 (OH & NH), 3160, 3058 (CH aromatic), 2948, 2809 (CH
aliphatic), 1705, 1659 (amidic C]O), 1548 (C]N), 1495 (C]C
aromatic); 1H NMR (DMSO-d6) d 0.92 (d, J ¼ 7.2 Hz, 3H, piperi-
dine CH3), 1.27e1.43 (m, 5H, piperidinyl H-3, H-4, H-5), 2.13 (t,
J ¼ 5.4 Hz, 4H, piperidinyl H-2, H-6), 3.41 (s, 3H, purinyl
N3eCH3), 3.58 (s, 3H, purinyl N1eCH3), 3.66 (s, 2H, CH2N), 4.99
(s, 2H, CH2CO), 6.70e6.73 (m, 2H, phenyl H-2, H-6), 7.33 (d,
J ¼ 8.1 Hz, 1H, phenyl H-5), 7.77 (s, 1H, purinyl H-8), 9.31 (s, 1H,
NH, D2O exchangeable), 10.41 (s, 1H, OH, D2O exchangeable);
EIMS 441 (Mþ 1). Anal. Calcd for C22H28N6O4: C, 59.99; H, 6.41;
N, 19.08. Found: C, 60.14; H, 6.19; N, 18.84.
2.1.1.3. 4-[(4-benzothiazol-2-yl-phenylimino)methyl]-2-
dimethylaminomethylphenol (5a). Amixture of dimethylamine
(0.005 mol) and formaldehyde solution (37e40%) (0.4 mL,
0.005mol) in absolute ethanol (5mL)was added to a solution of
4-[(4-benzothiazol-2-yl-phenylimino)-methyl]-phenol (4)
(1.65 gm, 0.005 mol) in absolute ethanol (10 mL). The reaction
mixture was heated under reflux for 5 h, allowed to cool to
room temperature and poured onto ice cooled water. The
formed precipitate was filtered off, dried and crystallized from
aqueous ethanol to give 1.94 g of 5a (65% yield);mp 161e163 C;
IR (cm1) 3420 (OH), 3104, 2955 (CH aromatic), 2924, 2851 (CH
aliphatic), 1594 (C]N), 1500 (C]C aromatic); 1H NMR (DMSO-
d6) d 2.27 (s, 6H, H3CeNeCH3), 3.58 (s, 2H, CH2N), 7.34e8.12 (m,
12H, phenol H-3, H-5, H-6, phenyl H-2, H-3, H-5, H-6, benzo-
thiazolyl H-4, H-5, H-6, H-7, N]CH), 10.27 (s, 1H, OH, D2O
exchangeable); EIMS 387 (Mþ). Anal. Calcd for C23H21N3OS: C,
71.29; H, 5.46; N, 10.84. Found: C, 70.98; H, 5.29; N, 10.58.
2.1.1.4. 4-[(4-benzothiazol-2-yl-phenylimino)methyl]-2-(piper-
idin-1-ylmethyl)phenol (5b). The title compound 5b was syn-
thesized, using a similar procedure to that described for the
preparation of 5a, by using piperidine in place of dimethyl-
amine, in 62% yield as a pale brown powder;mp 110e112 C; IR
(cm1) 3420 (OH), 3096, 3027 (CH aromatic), 2932, 2801 (CH
aliphatic), 1596 (C]N), 1516 (C]C aromatic); 1H NMR (DMSO-
d6) d 1.00e1.12 (m, 6H, piperidine H-3, H-4, H-5), 2.22 (t, 4H,
J¼ 5.1 Hz, piperidineH-2, H-6), 3.96 (s, 2H, CH2N), 7.34e8.12 (m,
12H, phenol H-3, H-5, H-6, phenyl H-2, H-3, H-5, H-6, benzo-
thiazolyl H-4, H-5, H-6, H-7, N]CH), 10.27 (s, 1H, OH, D2O
exchangeable); EIMS 427 (Mþ). Anal. Calcd for C26H25N3OS: C,
73.04; H, 5.89; N, 9.83. Found: C, 73.23; H, 5.73; N, 10.13.
2.1.1.5. N-(4-Benzothiazol-2-ylphenyl)-2-(4-
hydroxyphenylamino)acetamide (7). A mixture of N-(4-
benzothiazol-2-ylphenyl)-2-chloroacetamide (6) (1.5 g,
0.005 mol), 4-aminophenol (0.5 g, 0.005 mol) and few crystals
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under reflux for 11 h. The formed precipitate was filtered
while hot, washed with hot ethanol (5 mL). After drying, the
precipitate was suspended in water and neutralized with so-
dium carbonate solution (20%) then filtered, washed with
water, dried and crystallized from n-butanol to afford 7. m.p.
235e237, yield: 1.0 g, 53.7%; IR (cm1) 3424, 3291 (OH & NH),
3102, 3031 (CH aromatic), 2905 (CH aliphatic), 1676 (amidic C]
O), 1596 (C]N), 1528 (C]C aromatic); 1H NMR (DMSO-d6) d 4.31
(s, 2H, CH2C]O), 5.44 (s, 1H, CH2NH, D2O exchangeable),
6.50e8.09 (m, 12H, phenol H-2, H-3, H-5, H-6, phenyl H-2, H-3,
H-5, H-6, benzothiazolyl H-4, H-5, H-6, H-7), 8.58 (s, 1H, NHCO,
D2O exchangeable), 10.26 (s, 1H, OH, D2O exchangeable); EIMS
375 (Mþ). Anal. Calcd for C21H17N3O2S: C, 67.18; H, 4.56; N,
11.19. Found: C, 66.91; H, 4.59; N, 11.39.
2.1.1.6. N-(4-Benzothiazol-2-ylphenyl)-2-(3-
dimethylaminomethyl-4-hydroxyphenylamino)aceta-mide (8a).
A mixture of dimethylamine (0.005 mol), formaldehyde solu-
tion (37e40%) (0.4 mL, 0.005 mol) and absolute ethanol (5 mL)
was added portionwise to a suspension of compound 7 (1.87 g,
0.005 mol) in absolute ethanol (10 mL). The reaction mixture
was heated under reflux for 5 h then allowed to cool to room
temperature. The obtained precipitate was filtered, dried and
crystallized from dimethylformamide/water to give 8a 1.36 g
(63%); mp 209e211 C; IR (cm1) 3417, 3275 (OH & NH), 3104,
3054 (CH aromatic), 2919, 2836 (CH aliphatic), 1681 (amidic C]
O), 1601 (C]N), 1518 (C]C aromatic); 1H NMR (DMSO-d6) d 2.28
(s, 6H, H3CeNeCH3), 3.99 (s, 2H, CH2N), 4.49 (s, 2H, CH2CO), 5.41
(s, 1H, CH2NH, D2O exchangeable), 6.50e8.14 (m, 11H,
hydroxyphenyl H-2, H-5, H-6, phenyl H-2, H-3, H-5, H-6, ben-
zothiazolyl H-4, H-5, H-6, H-7), 8.51 (s, 1H, NHCO, D2O
exchangeable), 10.05 (s, 1H, OH, D2O exchangeable); EIMS 432
(Mþ). Anal. Calcd for C24H24N4O2S: C, 66.64; H, 5.59; N, 12.95.
Found: C, 66.40; H, 5.29; N, 12.77.
2.1.1.7. N-(4-Benzothiazol-2-yl-phenyl)-2-[4-hydroxy-3-(4-
methylpiperidin-1-ylmethyl)phenyl-amino]acetamide (8b). The
title compound 8bwas synthesized, using a similar procedure
to that described for the preparation of 8a, by using 4-
methylpiperidine in place of dimethylamine, in 69% yield as
a pale brown powder; mp 170e172 C; IR (cm1) 3420, 3250 (OH
&NH), 3103, 3054 (CH aromatic), 2949, 2869 (CH aliphatic), 1694
(amidic C]O), 1601 (C]N), 1519 (C]C aromatic); 1H NMR
(DMSO-d6) d 0.92 (d, J ¼ 7.2 Hz, 3H, piperidine CH3), 1.27e1.43
(m, 5H, piperidine H-3, H-4, H-5), 2.13 (t, 4H, J ¼ 5.4 Hz, piper-
idine H-2, H-6), 3.66 (s, 2H, CH2N), 4.49 (s, 2H, CH2CO), 5.41 (s,
1H, CH2NH, D2O exchangeable), 6.50e8.14 (m, 11H, hydrox-
yphenyl H-2, H-5, H-6, phenyl H-2, H-3, H-5, H-6, benzothia-
zolyl H-4, H-5, H-6, H-7), 8.51 (s, 1H, NHCO, D2O exchangeable),
10.05 (s, 1H, OH, D2O exchangeable); EIMS 486 (M
þ). Anal. Calcd
for C28H30N4O2S: C, 69.11; H, 6.21; N, 11.51. Found: C, 69.09; H,
5.81; N, 11.67.
2.1.2. General procedure for the preparation of 4-(thiazol-2-
ylazo)-2-substituted-methyl-phenol derivatives (11aed)
To a solution of the appropriate azo dye 10a or 10b (1.4 g,
0.005 mol) in absolute ethanol (10 mL), a mixture of the
respective secondary amine (0.005 mol) and formaldehyde
solution (37e40%) (0.4 mL, 0.005 mol) in absolute ethanol(5 mL) was added. The reaction mixture was heated under
reflux for 5 h then set-aside overnight. The solvent was
distilled off under reduced pressure. The residue left was
dissolved in the least amount of ethanol, precipitated with
water, filtered, dried and crystallized from aqueous ethanol to
afford the Mannich bases 11aed. Physical and spectral data
for 11aed are listed below.
2.1.2.1. 2-Diethylaminomethyl-4-(4-phenylthiazol-2-ylazo)-
phenol (11a). Yield, 60%; mp 99e101 C; IR (cm1) 3422 (OH),
3105, 2957 (CH aromatic), 2924, 2822 (CH aliphatic), 1596 (C]
N), 1543 (N]N), 1501 (C]C aromatic); 1HNMR (DMSO-d6) d 0.96
(t, J¼ 7.2 Hz, 6H, H3CeH2CeNeCH2eCH3), 2.74 (q, J¼ 7.2 Hz, 4H,
H3CeH2CeNeCH2eCH3), 4.04 (s, 2H, CH2N), 6.76e8.21 (m, 9H,
phenol H-2, H-5, H-6, 5 phenyl protons, thiazolyl H-5), 9.87 (s,
1H, OH, D2O exchangeable); EIMS 366 (M
þ). Anal. Calcd for
C20H22N4OS: C, 65.55; H, 6.05; N, 15.29. Found: C, 65.26; H, 5.79;
N, 15.55.
2.1.2.2. 2-(4-methylpiperazin-1-ylmethyl)-4-(4-phenylthiazol-
2-ylazo) phenol (11b). Yield, 51%; mp 179e182 C; IR (cm1)
3422 (OH), 3102, 2941 (CH aromatic), 2881, 2824 (CH aliphatic),
1582 (C]N), 1542 (N]N), 1487 (C]Caromatic); 1HNMR (DMSO-
d6) d 2.29 (s, 3H, piperazine CH3), 2.45e2.49 (m, 8H, piperazine
H-2, H-3, H-5, H-6), 3.97 (s, 2H, CH2N), 6.79e8.24 (m, 9H, phenol
H-2, H-5, H-6, 5 phenyl protons, thiazolyl H-5), 9.86 (s, 1H, OH,
D2O exchangeable); EIMS 393 (M
þ). Anal. Calcd for C21H23N5OS:
C, 64.10; H, 5.89; N, 17.80. Found: C, 64.39; H, 5.71; N, 17.74.
2.1.2.3. 2-(4-Hydroxy-3-piperidin-1-ylmethylphenylazo)-4-
methylthiazole-5-carboxylic acid ethyl ester (11c). Yield, 66%;
mp 87e90 C; IR (cm1) 3424 (OH), 3040, 2932 (CH aromatic),
2856, 2808 (CH aliphatic), 1712 (C]O ester), 1602 (C]N), 1583
(N]N), 1522 (C]C aromatic); 1H NMR (DMSO-d6) d 1.0e1.1 (m,
6H, piperidine H-3, H-4, H-5), 1.39 (t, J ¼ 7.2 Hz, 3H, OCH2CH3),
2.30 (t, J¼ 5.4 Hz, 4H, piperidine H-2, H-6), 2.81 (s, 3H, CH3), 3.75
(s, 2H, CH2N), 4.36 (q, J ¼ 7.2 Hz, 2H, OCH2CH3), 6.94 (d,
J ¼ 8.1 Hz, 1H, phenyl H-5), 7.73 (s, 1H, phenyl H-2); 7.91 (d,
J¼ 8.1Hz, 1H, phenyl H-6), 10.25 (s, 1H, OH, D2O exchangeable);
EIMS 388 (Mþ). Anal. Calcd for C19H24N4O3S: C, 58.74; H, 6.23; N,
14.42. Found: C, 58.54; H, 6.62; N, 14.78.
2.1.2.4. 2-(4-hydroxy-3-morpholin-4-ylmethylphenylazo)-4-
methylthiazole-5-carboxylic acid ethyl ester (11d). Yield, 42%;
mp 100e102 C; IR (cm1) 3397 (OH), 3040, 2930 (CH aromatic),
2847, 2822 (CH aliphatic), 1712 (C]O ester), 1581 (C]N), 1544
(N]N), 1518 (C]C aromatic); 1H NMR (DMSO-d6) d 1.38 (t,
J ¼ 7.2 Hz, 3H, OCH2CH3), 2.12 (t, J ¼ 5.7 Hz, 4H, H2CeNeCH2 of
morpholine moiety), 2.54 (s, 3H, CH3), 3.98 (s, 2H, CH2N), 4.37
(q, J ¼ 7.2 Hz, 2H, OCH2CH3), 4.68 (t, J ¼ 5.7 Hz, 4H, H2CeOeCH2
of morpholine moiety), 6.95 (d, J ¼ 8.1 Hz, 1H, phenyl H-5), 7.74
(s, 1H, phenyl H-2), 7.89 (d, J ¼ 8.1 Hz, 1H, phenyl H-6), 10.23 (s,
1H, OH, D2O exchangeable); EIMS 390 (M
þ). Anal. Calcd for
C18H22N4O4S: C, 55.37; H, 5.68; N, 14.35. Found: C, 55.57; H, 5.87;
N, 14.25.
2.1.3. General procedure for the preparation of 4-(2-amino-4-
substituted-thiazol-5-ylazo) phenols (12aeb)
4-aminophenol (1.1 g, 0.01 mol) was dissolved in a mixture of
concentrated sulphuric acid (0.7 mL), water (5 mL) and
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dium nitrite (0.76 g, 0.011 mol) in water (2 mL) was added drop
wise while stirring to the above solution, stirring was
continued for further 20min. The diazonium salt solutionwas
filtered onto a well cooled solution of 4-substituted-thiazol-2-
ylamine 9a or 9b (0.01 mol) and sodium acetate (2.5 gm,
0.03mol) in aqueous ethanol (30mL) and stirred at 5 C for 2 h.
The formed precipitate was filtered, washed well with water,
dried and crystallized from the appropriate solvent to yield
12aeb as orange crystals. Physical and spectral data for 12aeb
are listed below.
2.1.3.1. 4-(2-Amino-4-phenylthiazol-5-ylazo)phenol (12a).
Yield, 91%; mp 198e200 C (crystallized from methanol); IR
(cm1): 3486e3333 (OH & NH2), 3133, 3020 (CH aromatic), 1601
(C]N), 1580 (N]N), 1498 (C]C aromatic); 1H NMR (DMSO-d6)
d 5.80 (s, 2H, NH2, D2O exchangeable), 6.87e8.18 (m, 9H, 5
phenyl protons and 4 phenol protons), 8.50 (s, 1H, OH, D2O
exchangeable); EIMS 297 (Mþ 1). Anal. Calcd for C15H12N4OS:
C, 60.79; H, 4.08; N, 18.91. Found: C, 60.89; H, 4.05; N, 18.53.
2.1.3.2. 4-(2-Amino-4-p-tolyl–thiazol-5-ylazo)phenol (12b).
Yield, 80%; mp 247e248 C (crystallized from chloroform/
diethyl ether); IR (cm1): 3475, 3345 (OH & NH2), 3100, 3028 (CH
aromatic), 2922, 2853 (CH aliphatic), 1624 (C]N), 1582 (N]N),
1528 (C]C aromatic); 1H NMR (DMSO-d6) d 2.36 (s, 3H, CH3);
6.85e8.12 (m, 10H, 4 tolyl protons and 4 phenol protons & NH2
(D2O exchangeable)), 10.0 (s, 1H, OH, D2O exchangeable); EIMS
311 (Mþ 1). Anal. Calcd for C16H14N4OS: C, 61.92; H, 4.55; N,
18.05. Found: C, 62.08; H, 4.52; N, 17.98.
2.1.4. General procedure for the preparation of 4-(2-amino-4-
substituted-thiazol-5-ylazo)-2-substituted-methylphenols
(13aed)
To a solution of the thiazole derivative 12a or 12b (0.01 mol) in
absolute ethanol (10 mL), a mixture of the respective sec-
ondary amine (0.01 mol) and formaldehyde solution (37e40%)
(0.8 mL, 0.01 mol) in absolute ethanol (5 mL) was added. The
reaction mixture was heated under reflux for 5 h then cooled
and poured onto ice cooled water. The formed precipitate was
filtered, dried and crystallized from aqueous ethanol to afford
13aed. Physical and spectral data for 13aed are listed below.
2.1.4.1. 4-(2-Amino-4-phenylthiazol-5-ylazo)-2-
Diethylaminomethylphenol (13a). Yield, 75%; mp 155e158 C;
IR (cm1) 3374e3284 (OH & NH2), 3060, 2971 (CH aromatic),
2929, 2862 (CH aliphatic), 1584 (C]N), 1528 (N]N), 1478 (C]C
aromatic); 1H NMR (DMSO-d6) d 1.32 (t, J ¼ 7.2 Hz, 6H, CH2CH3),
3.84 (s, 2H, CH2N); 4.28 (q, J ¼ 7.2 Hz, 4H, CH2CH3), 6.13 (s, 2H,
NH2, D2O exchangeable), 6.81e8.13 (m, 8H, 5 phenyl protons
and 3 phenol protons), 9.22 (s, 1H, OH, D2O exchangeable);
EIMS 381 (Mþ). Anal. Calcd for C20H23N5OS: C, 62.97; H, 6.08; N,
18.36. Found: C, 63.11; H, 6.32; N, 18.26.
2.1.4.2. 4-(2-Amino-4-phenylthiazol-5-ylazo)-2-piperidin-1-
ylmethylphenol (13b). Yield, 62%; mp 145e148 C; IR (cm1):
3336e3278 (OH & NH2), 3060, 2960 (CH aromatic), 2929, 2872
(CH aliphatic), 1595 (C]N), 1516 (N]N), 1477 (C]C aromatic);
1H NMR (DMSO-d6) d 1.01e1.11 (m, 6H, piperidine H-3, H-4, H-
5), 2.30 (t, 4H, J¼ 5.7 Hz, piperidine H-2, H-6), 4.10 (s, 2H, CH2N);6.23 (s, 2H, NH2, D2O exchangeable); 6.84e8.16 (m, 8H, 5 phenyl
protons and 3 phenol protons), 9.18 (s, 1H, OH, D2O
exchangeable); EIMS 393 (Mþ). Anal. Calcd for C21H23N5OS: C,
64.10; H, 5.89; N, 17.80. Found: C, 64.40; H, 5.91; N, 17.49.
2.1.4.3. 4-(2-Amino-4-p-tolylthiazol-5-ylazo)-2-
dimethylaminomethylphenol (13c). Yield, 45%; mp 100e102 C;
IR (cm1): 3312, 3199 (OH & NH2), 3028, 2972 (CH aromatic),
2925, 2894 (CH aliphatic), 1599 (C]N), 1536 (N]N), 1489 (C]C
aromatic); 1H NMR (DMSO-d6) d 2.28 (s, 6H, H3CeNeCH3), 2.33
(s, 3H, CH3), 3.85 (s, 2H, CH2N), 6.83e8.06 (m, 9H, 4 tolyl protons
and 3 phenol protons & NH2 (D2O exchangeable)), 10.49 (s, 1H,
OH, D2O exchangeable); EIMS 367 (M
þ). Anal. Calcd for
C19H21N5OS: C, 62.10; H, 5.76; N, 19.06. Found: C, 62.43; H, 5.99;
N, 19.00.
2.1.4.4. 4-(2-Amino-4-p-tolyl-thiazol-5-ylazo)-2-morpholin-4-
ylmethylphenol (13d). Yield, 58%; mp 119e121 C; IR (cm1):
3362, 3292 (OH & NH2), 3066, 2984 (CH aromatic), 2917, 2857
(CH aliphatic), 1589 (C]N), 1535 (N]N), 1488 (C]C aromatic);
1H NMR (DMSO-d6) d 2.13 (t, 4H, J ¼ 5.7 Hz, H2CeNeCH2 of
morpholinemoiety), 2.32 (s, 3H, CH3), 3.88 (s, 2H, CH2N), 4.69 (t,
4H, J ¼ 5.7 Hz, H2CeOeCH2 of morpholine moiety), 6.86e8.08
(m, 9H, 4 tolyl protons and 3 phenol protons & NH2 (D2O
exchangeable)), 10.45 (s, 1H, OH, D2O exchangeable); EIMS 409
(Mþ). Anal. Calcd for C21H23N5O2S: C, 61.59; H, 5.66; N, 17.10.
Found: C, 61.65; H, 5.37; N, 17.18.
2.2. Antimicrobial evaluation
The antimicrobial activity was determined using the agar
dilution technique using ciprofloxacin and fluconazole as
positive control and the solvent, dimethylsulfoxide (DMSO) as
a negative control according to a previously reported proce-
dure (Lorian, 1980).3. Results and discussion
3.1. Chemistry
Reacting solution of 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-
tetrahydropurin-7-yl)-N-(4-hydroxyphenyl)acetamide (1) in
dimethylformamide with a mixture of the appropriate sec-
ondary amine (diethylamine or 4-methylpiperidine) and
formaldehyde in glacial acetic acid yielded 2a and 2b in high
yields (67% and 80%) respectively (Scheme 1). The structures
of 2a and 2b were confirmed on the basis of their elemental
and spectral data. The 1H NMR spectrum of 2a showed the
appearance of a triplet signal at d 0.95 and a quartet one at
d 2.74 attributed to (H5C2eNeC2H5) in addition to a singlet at
d 3.55 indicating CH2N. Also, the
1H NMR spectrum of 2b dis-
played the presence of a doublet peak at d 0.92 indicating the
methyl protons attached to the piperidine moiety, a multiplet
peak at d 1.27e1.43 with 5H integration attributed to piperi-
dine H-3, H-4, H-5, a triplet peak at d 2.13 with 4H integration
attributed to piperidine H-2, H-6, and a singlet signal at d 3.66
corresponding to CH2N.
Furthermore, heating equimolar amounts of 4-
benzothiazol-2-yl-phenylamine (3) with 4-
Scheme 1 e Synthetic protocol for compounds 2aeb. Reagents and conditions: (a) diethylamine or 4-methylpiperidine,
formaldhyde, ethanol, reflux, 5 h.
b e n i - s u e f un i v e r s i t y j o u rn a l o f b a s i c a n d a p p l i e d s c i e n c e s 4 ( 2 0 1 5 ) 5 2e5 956hydroxybenzaldehyde in ethanol containing catalytic amount
of glacial acetic acid yielded 4-[(4-benzothiazol-2-yl-phenyl-
imino)methyl]phenol (4). Subjecting 4 to Mannich reaction
using formaldehyde and secondary amine (dimethylamine or
piperidine) in ethanol afforded 5a and 5b as revealed in their
1H NMR spectra which showed singlet at 3.96 or 3.98 ppm
assigned to the methyline protons of the CH2N in addition to
signals assigned to the alkylamino groups. Moreover, reacting
3 with chloroacetyl chloride yielded N-(4-benzothiazol-2-yl-
phenyl)-2-chloroacetamide (6) which upon reaction with 4-
aminophenol led to the corresponding acetamide 7. TreatingScheme 2 e Synthetic protocol for compounds 5aeb and 8aeb. Re
acetic acid, 20 h; (b) dimethylamine or piperidine for 4 and dim
ethanol, reflux, 5 h; (c) chloroacetyl chloride, benzene, reflux, 30
11 h.the latter with formaldhyde and secondary amines (dime-
thylamine or 4-methylpiperidine) gave the target Mannich
bases 8a and 8b (Scheme 2). The 1H NMR spectrum of 8a and
8b showed the characteristic singlet at 3.99 or 3.66 ppm
assigned to the methyline protons of the CH2N in addition to
signals assigned to the dimethylamino and 4-
methylpiperidino moieties.
On the other hand, the 4-(4-arylthiazol-2-ylazo)phenol
(10a, 10b) could be obtained by diazotizing the corresponding
starting amines in acetic acid with nitrosyl sulphuric acid.
Reacting the phenolic azo dye 10a, 10b with formaldehydeagents and conditions. (a) 4-hydroxybenzaldhyde, ethanol,
ethylamine or 4-methylpiperidine for 7, formaldhyde,
min; (d) 4-aminophenol, potassium iodide, ethanol, reflux
Scheme 3 e Synthetic protocol for compounds 11aed and 13aed. Reagents and conditions: (a) i- NaNO2, H2SO4, acetic acid,
5 C, 2 h, ii-phenol, NaOH, 5 C, 2 h; (b) diethylamine or 4-methylpiperazine for 10a, piperidine or morpholine for 10b,
diethylamine or piperidine for 12a and dimethylamine, or morpholine for 12b, formaldhyde, ethanol, reflux, 5 h; (c) sodium
acetate, ethanol, 5 C, 2 h.
b e n i - s u e f u n i v e r s i t y j o u r n a l o f b a s i c a n d a p p l i e d s c i e n c e s 4 ( 2 0 1 5 ) 5 2e5 9 57and secondary amine (diethylamine, 4-methylpiperazine,
piperidine or morpholine) in ethanol afforded the target
compounds 11aed. The 1H NMR spectrum of 11aed showed
the characteristic singlet at 3.75e4.04 ppm assigned to the
methyline protons of the CH2N in addition to signals assigned
to the diethylamino, 4-methylpiperazino, piperidino and
morpholino moieties. Moreover, reacting 4-substituted-thia-
zole-2-ylamine 9a, 9b with p-aminophenol diazonium salt
solution in presence of sodium acetate yielded the corre-
sponding azo phenols 12a, 12b in high yields (80% and 91%
respectively). The reaction of 12a, 12b according to Mannich
reaction conditions with the appropriate secondary amine
(diethylamine, piperidine, dimethylamine or morpholine)
yielded the target compounds 13aed (Scheme 3). The 1H-NMR
spectrum of 13aed showed the characteristic singlet at3.84e4.10 ppm assigned to the methyline protons of the CH2N
in addition to signals assigned to the diethylamino, piper-
idino, dimethylamino or morpholino groups.
3.2. Pharmacological screening
The antimicrobial activity of the synthesized compounds
2aeb, 5aeb, 8aeb, 11aed, and 13aed was studied using the
agar dilution technique using ciprofloxacin and fluconazole as
positive control and the solvent, dimethylsulfoxide (DMSO) as
a negative control. The synthesized compounds were
screened for their in vitro antimicrobial testing using six
selected standard isolates as a representative examples of
different types of microorganisms as follows: gram-positive
both non sporulated bacteria as Staphylococus aureus and
Table 1 e MIC (mg/mL) of heterocyclic systems substituted with dialkylaminoalkyl-o-cresols.
Comp no. Ps. aeruginosa E. coli B. subtilis S. aureus MRSA C. albicans
2a >800 >800 >800 >800 >800 >800
2b >800 >800 >800 >800 >800 >800
5a >800 800 50 50 50 50
5b >800 >800 >800 >800 >800 >800
8a >800 800 200 50 50 200
8b >800 >800 800 100 100 200
11a >800 800 12.5 12.5 12.5 800
11b >800 800 25 25 25 25
11c >800 800 400 200 200 12.5
11d >800 >800 >800 >800 >800 >800
13a >800 400 25 25 25 400
13b >800 400 50 200 200 >800
13c >800 200 12.5 12.5 12.5 12.5
13d >800 400 12.5 12.5 12.5 >800
DMSO >800 >800 >800 >800 >800 >800
Ciprofloxacin <6.25 50 <6.25 <6.25 12.5 400
Fluconazole >800 >800 >800 >800 >800 6.25
b e n i - s u e f un i v e r s i t y j o u rn a l o f b a s i c a n d a p p l i e d s c i e n c e s 4 ( 2 0 1 5 ) 5 2e5 958micithillin resistant Staphylococus aureus (MRSA), sporulated
as Bacillus subtilis, gram-negative bacteria both sensitive as
Escherichia coli, resistant as Pseudomonas aeruginosa and a fun-
gus as Candida albicans. The results are recorded in Table 1 and
it was clear that there is variability in the susceptibilities of the
different organisms to the different tested compounds. Gram-
negative bacteria were the most resistant organism while
gram-positive bacteria were the most sensitive. Some com-
pounds showed both antibacterial and antifungal activity,
while others showed antibacterial activity with no antifungal
activity and vice versa. Compound 13c showed the highest
activity against gram-positive and gram-negative bacteria and
fungi, also compound 5a showed a potent activity against
both gram-positive bacteria and fungi. Compounds 11a, 13a
and 13d have a significant activity against gram-positive
bacteria and no activity against fungi. A moderate activity
against gram-positive bacteria and fungi was shown by com-
pound 8a and 11b.4. Conclusion
We can conclude that the combination of phenolic Mannich
bases with a thiazole ring system via azo group (11a, 13a, 13b,
13c) showed a potent antimicrobial activity while the incor-
poration of benzothiazole nucleus with alkylamino-o-cresols
through an amidic linkage (8a) exhibited a moderate antimi-
crobial activity. On the other hand, the incorporation of
Mannich bases with purine nucleus (2aeb) resulted in prod-
ucts with no antimicrobial activity.r e f e r e n c e s
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